The latest satisfaction survey results from Quilaban confirm the trust placed in the company by […]
Genetic disorders are among the leading causes of admission to neonatal and paediatric intensive care […]
We proudly celebrate 5 years of partnership between Quilaban and Illumina, a global leader in […]
Monofar 100 mg/ml solution for injection/infusion
Customer and Supplier Satisfaction Remains at Excellent Levels
Rapid Genetic Diagnosis: What Portugal is missing out on
5 Years of partnership between Quilaban and Illumina
Quilaban Recognised at the 2024 People Engagement Awards
